Human TL1A/TNFSF15 ELISA Kit

사용자 리뷰
제품 번호/규격
가격
수량
CEA-C090-96tests
$565.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Product Overview

    Human TL1A/TNFSF15 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human TL1A/TNFSF15 that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ELISA Kit provides several benefits:

    1. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    2. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    3. Simplified and straightforward protocols and ready-to-use reagents to save assay time.

  • Product Specifications

    Assay Type
    Sandwich-ELISA
    Analyte
    TL1A
    Format
    96-wells plate breakable into 12 x 8 wells strips
    Reactivity
    Human
    Sensitivity
    7.5 pg/mL
    Assay Time
    2.75 hr
    Sample volume
    50 μL
    Range
    12.5 pg/mL-800 pg/mL
    Sample Type
    For the quantitative determination of human TL1A in serum, plasma and cell supernatant.

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Application

    The kit is developed for quantitative detection of natural and recombinant human TL1A in serum, plasma and cell culture supernatants.

    It is for research use only.

  • Workflow

    TL1A Workflow

  • Storage

    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    CEA090-C01
    Pre-coated Anti-TL1A Antibody Microplate
    1 plate
    CEA090-C02
    Human TL1A Standard
    80 ng×2
    CEA090-C03
    Biotin-Anti-TL1A Antibody Con. Solution
    100 μL
    CEA090-C04
    Biotin-Antibody Dilution Buffer
    8 mL
    CEA090-C05
    Streptavidin-HRP Con. Solution
    500 μL
    CEA090-C06
    Streptavidin-HRP Dilution Buffer
    15 mL
    CEA090-C07
    20× Washing Buffer
    50 mL
    CEA090-C08
    Sample Dilution Buffer
    15 mL×2
    CEA090-C09
    Substrate Solution
    12 mL
    CEA090-C10
    Stop Solution
    6 mL
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • Typical Data 

    Please refer to DS document for the assay protocol.

     TL1A TYPICAL DATA

    For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was cal-culated based on the results of the standard curve. The minimum detectable con-centration of TL1A is less than 7.5 pg/mL.

Validation
  • Sample Values

    Serum sample: Thirty healthy serum samples were evaluated for the concentrations of human TL1A in assay. The detection rate is 100%.

     TL1A SAMPLE VALUES
  • Intra-Assay Statistics

    Ten replicates of each of three samples containing different TL1A concentrations were tested in one assay. Acceptable criteria: CV<10%.

     TL1A INTRA-ASSAY STATISTICS
  • Inter-Assay Statistics

    Three samples containing different concentrations of TL1A were tested in independent assays. Acceptable criteria: CV<15%.

     TL1A INTER-ASSAY STATISTICS
  • Recovery

    Recombinant TL1A was spiked into three human serum samples, and then analyzed. The average recovery of TL1A for serum samples is 95.24%.

     TL1A RECOVERY

사용자 리뷰
댓글 남기기

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Tumor necrosis factor superfamily member 15

  • 카테고리:

  • 상장 의약품 수:

    0 상세

  • 임상 의약품 수:

    18 상세

  • 최고 개발 단계:

    Phase 3 Clinical

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호